Rodgers Brothers’s ResMed RMD Stock Holding History

Rodgers Brothers’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-803	Closed	-$212K	–	211
2021 Q3	$212K	Buy	+803	New	+$220K	0.04%	186

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Rodgers Brothers's RMD Position: Q4 2021 in Review

Rodgers Brothers sold out of ResMed (RMD) in Q4 2021, closing a stake of 803 shares — an estimated $212K sold.

Rodgers Brothers first reported a position in RMD in Q3 2021 and held it in 1 quarter. The position peaked at $212K in Q3 2021. 723 funds tracked by Wall St. Rank hold RMD as of Q4 2021.

Rodgers Brothers reported no remaining ResMed position as of Q4 2021 after selling out during the quarter.
Rodgers Brothers sold 803 ResMed shares in Q4 2021, an estimated $212K.
Rodgers Brothers first reported a position in ResMed in Q3 2021 and held it in 1 quarter.
Rodgers Brothers's ResMed position peaked at $212K in Q3 2021.
723 funds tracked by Wall St. Rank held ResMed as of Q4 2021.

Based on Rodgers Brothers's 13F filing for Q4 2021, filed 14 Feb 2022.